India will work on developing a vaccine for the deadly H1N1 flu as the new killer virus swept parts of the world. The Government at a high-level meeting held in the capital on Tuesday chalked out a scientific framework for manufacturing a vaccine for the dreaded disease. No case of H1N1 flu has been reported in India so far.
“We have decided to form a short-term and a long-term strategy for tackling the dreaded disease,” said Secretary, Department of Health Research, V N Katoch. While the short-term strategy would include a plan of action to tackle the outbreak of a pandemic, the long-term method would focus on creation of a vaccine and vaccination of population.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
